Top

Reactions Weekly

Published in:

01-04-2024 | Lenvatinib | Case report

Iodine-131/lenvatinib

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Papini E, et al. Combined Treatment with Laser Ablation and Tyrosin Kinase Inhibitors. a Novel Multimodality Approach to Locally Advanced Thyroid Cancer?. Journal of the Endocrine Society 4 (Suppl.): A919 abstr. SUN-485, May 2020. Available from: URL: https://dx.doi.org/10.1210/jendso/bvaa046.1822 [abstract]

Title: Iodine-131/lenvatinib
Lack of efficacy
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keywords: Lenvatinib
Thyroid Cancer
Thyroid Cancer
Thyroid Cancer
Dysphonia
Dysphonia
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-56885-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Iodine-131/lenvatinib

Lack of efficacy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Cobimetinib

Tocilizumab

Propranolol

Levothyroxine-sodium

Ocrelizumab

Pembrolizumab